Cyclerion Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 84.55 K | $129.80 K | 95.26% | 2.62% |
| CITADEL ADVISORS LLC | 05/15/2026 | 18.26 K | $28.03 K | 100.00% | 0.57% |
| BLACKROCK, INC. | 05/13/2026 | 16.80 K | $26.04 K | 0.00% | 0.52% |
| 05/15/2026 | 16.14 K | $24.77 K | 100.00% | 0.50% | |
| KOVACK ADVISORS, INC. | 05/13/2026 | 10.00 K | $15.50 K | 100.00% | 0.31% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 7.35 K | $11.29 K | 100.00% | 0.23% |
| FMR LLC | 05/15/2026 | 4.74 K | $7.28 K | 0.00% | 0.15% |
| UBS GROUP AG | 05/05/2026 | 3.39 K | $5.26 K | 801.86% | 0.11% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 192 | $295 | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 130 | $201 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 100 | $155 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 04/15/2026 | 100 | $155 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 89 | $137 | -98.92% | 0.00% |
| 04/24/2026 | 72 | $112 | 0.00% | 0.00% | |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 5 | $8 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 4 | $6 | 100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 1 | $2 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SIREN, L.L.C. | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclerion Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Cyclerion Therapeutics Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 84,550
CITADEL ADVISORS LLC: 18,261
BlackRock, Inc.: 16,797
Kovack Advisors, Inc.: 10,000
VANGUARD FIDUCIARY TRUST CO: 7,353
FMR LLC: 4,740
5.02% of Cyclerion Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 797.90 K shares in the last 24 months. This purchase volume represents approximately $1.19 M in transactions.